Last updated: May 18, 2013: 10:31 AM
- Westlake Chemical Keeps Dividend Steady
- 4 Countries Where U.S. Dollars Are Worth the Least
- 7 Must-Watch Announcements for Bank Investors Next Week
- How Do You Spot a Stupid CEO?
- 5 Companies With Terrible Brand Loyalty
- These 6 States Tax Inheritances the Hardest
- Warren Buffett's Best Advice, and Why We Need to Be Reminded
- The World's 5 Most Debt-Ridden Countries
- Inland Real Estate Sets June Disbursement
- Report: Yahoo Nearing $1.1 Billion Acquisition of Tumblr
AOL Business News
- North Korea Fires Short Range Missiles
- Haircut Men Aren't So Attracted To?
- Bombshell Testimony at O.J. Hearing
- Teen's First Drive Ends in Heartbreak
- Regis Didn't See What Was Near Flame
BioHealth Investor Headlines
- Shouldn’t VIVUS Raise Capital Now? (VVUS)
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.